ES2060825T3 - Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa. - Google Patents
Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa.Info
- Publication number
- ES2060825T3 ES2060825T3 ES90102770T ES90102770T ES2060825T3 ES 2060825 T3 ES2060825 T3 ES 2060825T3 ES 90102770 T ES90102770 T ES 90102770T ES 90102770 T ES90102770 T ES 90102770T ES 2060825 T3 ES2060825 T3 ES 2060825T3
- Authority
- ES
- Spain
- Prior art keywords
- delayed
- therapeutic system
- percutanea
- mucosa
- active substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000003111 delayed effect Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- 210000004877 mucosa Anatomy 0.000 title 1
- 239000000126 substance Substances 0.000 abstract 9
- 230000003213 activating effect Effects 0.000 abstract 5
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Furan Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Steroid Compounds (AREA)
Abstract
SE HA INVENTADO UN SISTEMA TERAPEUTICO PARA EL SUMINISTRO TRANSDERMAL O TRANSMUCOSAL RETARDADO Y CONTROLADO DE SUSTANCIAS ACTIVADORAS QUE SE COMPONE DE UNA CAPA TRASERA IMPERMEABLE, UN DEPOSITO DE SUSTANCIAS AUXILIARES, UN DEPOSITO DE SUSTANCIAS ACTIVADORAS Y UNA CAPA PROTECTORA DESPRENDIBLE. EL DEPOSITO DE SUSTANCIAS ACTIVADORAS CONTIENE UNA SUSTANCIA EN ESTADO NO BIODISPONIBLE. LA SUSTANCIA AUXILIAR DEL CORRESPONDIENTE DEPOSITO TRANSFORMA LA SUSTANCIA ACTIVADORA HACIENDOLA BIODISPONIBLE. LOS DEPOSITOS DE SUSTANCIAS AUXILIARES Y SUSTANCIAS ACTIVADORAS SE CONECTAN SOLO INMEDIATAMENTE ANTES, O BIEN EN ALGUN MOMENTO DESPUES DE LA APLICACION, DE TAL MANERA QUE LA SUSTANCIA AUXILIAR ENTRE EN EL DEPOSITO DE SUSTANCIAS ACTIVADORAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3905050A DE3905050A1 (de) | 1989-02-18 | 1989-02-18 | Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii) |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2060825T3 true ES2060825T3 (es) | 1994-12-01 |
Family
ID=6374442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90102770T Expired - Lifetime ES2060825T3 (es) | 1989-02-18 | 1990-02-13 | Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5466466A (es) |
EP (1) | EP0384266B1 (es) |
JP (1) | JP2552190B2 (es) |
AT (1) | ATE108680T1 (es) |
AU (1) | AU627268B2 (es) |
CA (1) | CA2010218C (es) |
DD (1) | DD291928A5 (es) |
DE (2) | DE3905050A1 (es) |
DK (1) | DK0384266T3 (es) |
ES (1) | ES2060825T3 (es) |
FI (1) | FI105157B (es) |
IE (1) | IE66739B1 (es) |
NO (1) | NO303207B1 (es) |
PT (1) | PT93191B (es) |
ZA (1) | ZA901183B (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL105073A0 (en) † | 1992-03-17 | 1993-07-08 | Becton Dickinson Co | User activated iontophoretic device and method for using same |
US5730721A (en) | 1996-01-25 | 1998-03-24 | Vesture Corporation | Medical applicator and method |
DE19653606A1 (de) * | 1996-12-20 | 1998-06-25 | Roehm Gmbh | Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher |
US5912255A (en) * | 1998-02-27 | 1999-06-15 | Bussell; Letantia | Topical fluoroquinolone antibiotics combined with benzoyl peroxide |
DE19814083C2 (de) | 1998-03-30 | 2002-02-07 | Lohmann Therapie Syst Lts | Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen |
DE19814087A1 (de) * | 1998-03-30 | 1999-10-14 | Lohmann Therapie Syst Lts | Feuchtigkeitsaktivierbares therapeutisches System |
ES2240180T3 (es) | 1999-10-21 | 2005-10-16 | Alcon Inc. | Administracion sub-tenon de medicamentos. |
EP1473003B1 (en) | 1999-10-21 | 2008-11-19 | Alcon, Inc. | Drug delivery device |
US6416777B1 (en) | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
US7943162B2 (en) * | 1999-10-21 | 2011-05-17 | Alcon, Inc. | Drug delivery device |
US7060732B2 (en) * | 2000-12-12 | 2006-06-13 | Imaginative Research Associates, Inc. | Antibiotic/benzoyl peroxide dispenser |
US20060189552A1 (en) * | 2000-12-12 | 2006-08-24 | Mohan Vishnupad | Dispenser for dispensing three or more actives |
US20020193321A1 (en) * | 2000-12-12 | 2002-12-19 | Mohan Vishnupad | Dual dispenser for aesthitically acceptable delivery of anhydrous skin treatment compositions |
EP1387671A1 (en) | 2001-05-03 | 2004-02-11 | MASSACHUSETTS EYE & EAR INFIRMARY | Implantable drug delivery device and use thereof |
BR0210287A (pt) * | 2001-07-23 | 2005-12-13 | Alcon Inc | Dispositivo de administração de droga oftalmológica |
MXPA03011609A (es) | 2001-07-23 | 2004-07-01 | Alcon Inc | Dispositivo de entrega de droga oftalmica. |
EP1684669A4 (en) * | 2003-07-10 | 2008-01-02 | Alcon Inc | DEVICE FOR RELEASING AN OPHTHALMIC MEDICINAL PRODUCT |
AU2004285505B2 (en) * | 2003-10-28 | 2010-12-23 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device |
US7662855B2 (en) * | 2004-05-11 | 2010-02-16 | Imaginative Research Associates, Inc. | Retinoid solutions and formulations made therefrom |
US20060014834A1 (en) * | 2004-05-11 | 2006-01-19 | Mohan Vishnupad | Retinoid solutions and formulations made therefrom |
DE102004062614B4 (de) * | 2004-12-24 | 2011-12-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung |
JP5084496B2 (ja) * | 2005-02-04 | 2012-11-28 | 久光製薬株式会社 | 経皮吸収貼付剤 |
CA2616537A1 (en) | 2005-07-27 | 2007-02-01 | University Of Florida Research Foundation, Inc. | Small compounds that correct protein misfolding and uses thereof |
MX2008006379A (es) | 2005-11-29 | 2009-03-03 | Smithkline Beecham Corp | Metodo de tratamiento. |
TWI498136B (zh) * | 2007-10-09 | 2015-09-01 | Alcon Res Ltd | 用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法 |
TWI451862B (zh) * | 2007-10-09 | 2014-09-11 | Alcon Res Ltd | 用於眼睛注射的熱係數驅動藥丸尺寸 |
DE102008013701A1 (de) * | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit stabilisierter Membran |
US8632511B2 (en) | 2009-05-06 | 2014-01-21 | Alcon Research, Ltd. | Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device |
IN2012DN00352A (es) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
US20120232102A1 (en) | 2009-09-30 | 2012-09-13 | Chun-Fang Xu | Methods Of Administration And Treatment |
US8177747B2 (en) | 2009-12-22 | 2012-05-15 | Alcon Research, Ltd. | Method and apparatus for drug delivery |
CA2833474C (en) | 2011-04-18 | 2017-09-19 | Hisamitsu Pharmaceutical Co., Inc. | Method for producing patch, and patch |
CN103917093B (zh) | 2011-06-14 | 2017-08-11 | 比卡姆药品公司 | 视蛋白结合配体、组合物及使用方法 |
US9499464B2 (en) | 2011-10-19 | 2016-11-22 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
AU2012346214B2 (en) | 2011-11-30 | 2017-09-14 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
WO2013081642A1 (en) | 2011-12-01 | 2013-06-06 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4405616A (en) | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
US4756710A (en) * | 1985-04-05 | 1988-07-12 | Merck & Co., Inc. | pH-Mediated drug delivery system |
EP0249343B1 (en) | 1986-06-13 | 1992-01-08 | Alza Corporation | Moisture activation of transdermal drug delivery system |
EP0249475A3 (en) | 1986-06-13 | 1989-10-11 | Alza Corporation | Delayed percutaneous delivery |
EP0290262A3 (en) * | 1987-05-08 | 1990-12-12 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Improved nitrate therapy for angina pectoris |
US4781924A (en) * | 1987-11-09 | 1988-11-01 | Alza Corporation | Transdermal drug delivery device |
-
1989
- 1989-02-18 DE DE3905050A patent/DE3905050A1/de active Granted
-
1990
- 1990-01-25 AU AU48770/90A patent/AU627268B2/en not_active Ceased
- 1990-02-13 ES ES90102770T patent/ES2060825T3/es not_active Expired - Lifetime
- 1990-02-13 DE DE59006461T patent/DE59006461D1/de not_active Expired - Fee Related
- 1990-02-13 AT AT90102770T patent/ATE108680T1/de active
- 1990-02-13 EP EP90102770A patent/EP0384266B1/de not_active Expired - Lifetime
- 1990-02-13 DK DK90102770.6T patent/DK0384266T3/da active
- 1990-02-14 FI FI900740A patent/FI105157B/fi not_active IP Right Cessation
- 1990-02-14 JP JP2031657A patent/JP2552190B2/ja not_active Expired - Lifetime
- 1990-02-16 NO NO900748A patent/NO303207B1/no not_active IP Right Cessation
- 1990-02-16 PT PT93191A patent/PT93191B/pt active IP Right Grant
- 1990-02-16 ZA ZA901183A patent/ZA901183B/xx unknown
- 1990-02-16 DD DD90337919A patent/DD291928A5/de not_active IP Right Cessation
- 1990-02-16 IE IE58090A patent/IE66739B1/en not_active IP Right Cessation
- 1990-02-16 CA CA002010218A patent/CA2010218C/en not_active Expired - Fee Related
-
1994
- 1994-04-20 US US08/230,448 patent/US5466466A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE59006461D1 (de) | 1994-08-25 |
CA2010218A1 (en) | 1990-08-18 |
FI105157B (fi) | 2000-06-30 |
NO900748L (no) | 1990-08-20 |
DK0384266T3 (da) | 1994-11-21 |
IE66739B1 (en) | 1996-02-07 |
JPH03197420A (ja) | 1991-08-28 |
AU627268B2 (en) | 1992-08-20 |
CA2010218C (en) | 1998-04-28 |
EP0384266A3 (en) | 1990-11-22 |
PT93191B (pt) | 1998-01-30 |
AU4877090A (en) | 1990-08-23 |
EP0384266A2 (de) | 1990-08-29 |
ATE108680T1 (de) | 1994-08-15 |
DD291928A5 (de) | 1991-07-18 |
NO303207B1 (no) | 1998-06-15 |
US5466466A (en) | 1995-11-14 |
JP2552190B2 (ja) | 1996-11-06 |
PT93191A (pt) | 1990-08-31 |
IE900580L (en) | 1990-08-18 |
EP0384266B1 (de) | 1994-07-20 |
DE3905050C2 (es) | 1991-08-08 |
FI900740A0 (fi) | 1990-02-14 |
ZA901183B (en) | 1990-11-28 |
DE3905050A1 (de) | 1990-08-30 |
NO900748D0 (no) | 1990-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2060825T3 (es) | Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa. | |
IT8719064A0 (it) | Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive. | |
DK0740650T3 (da) | Codrugs som metode til styret transport af lægemiddel | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
DE3868037D1 (de) | Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe. | |
NO883837D0 (no) | Anordning til avgivelse av et middel i et foerste tidsrom etterfulgt av et andre, lengre tidsrom. | |
MX9202407A (es) | Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion. | |
AR005282A1 (es) | Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura. | |
DE3884044D1 (de) | Orale Darreichungsformen mit verzögerter Abgabe. | |
DE69940674D1 (de) | Orale verabreichung von adenosin analogen | |
ES2195308T3 (es) | Composicon farmaceutica de fenofibrato que presenta una biodisponibilidad elevada, y metodo para su preparacion. | |
EP0221732A3 (en) | Sustained release tablets | |
CL2008003941A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo. | |
CO5640120A2 (es) | Formulacion y metodods para el tratamiento de trombocitemia | |
ATE311227T1 (de) | Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne | |
IS1565B (is) | Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar | |
TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
MX9203557A (es) | Una forma de dosis para suministrar el farmaco benefico verapamil. | |
ES2089687T3 (es) | 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa. | |
AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
MX9205568A (es) | Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida. | |
AR024959A1 (es) | Una composicion farmaceutica liquida basada en paracetamol | |
BR9608255A (pt) | Sistema terapéutico transdérmico (stt) para a administração de testosterona | |
AR022621A1 (es) | Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina | |
ES2059312T3 (es) | Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 384266 Country of ref document: ES |